v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock Outstanding [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2024 135,155        
Balance at Dec. 31, 2024 $ 0 $ 183,693,000 $ (172,444,000) $ (41,000) $ 11,208,000
Warrant inducement and exercise of common stock warrants (in shares) 233,143        
Warrant inducement and exercise of common stock warrants $ 1,000 5,000 0 0 6,000
Warrants exercised (in shares) 150,801        
Warrants exercised $ 0 4,000 0 0 4,000
Stock-based compensation 0 485,000 0 0 485,000
Consolidated net loss 0 0 (5,904,000) 0 (5,904,000)
Cumulative translation adjustment 0 0 0 3,000 3,000
Net loss $ 0 0 (5,904,000) 0 (5,904,000)
Balance (in shares) at Mar. 31, 2025 565,099        
Balance at Mar. 31, 2025 $ 1,000 192,176,000 (178,348,000) (38,000) 13,791,000
Issued for cash - sale of common stock, pre-funded and common warrants (in shares) 46,000        
Issued for cash - sale of common stock, pre-funded and common warrants $ 0 1,000 0 0 1,000
Equity warrants issued $ 0 7,988,000 0 0 7,988,000
Balance (in shares) at Dec. 31, 2024 135,155        
Balance at Dec. 31, 2024 $ 0 183,693,000 (172,444,000) (41,000) 11,208,000
Consolidated net loss         (23,713,000)
Cumulative translation adjustment         3,000
Net loss         (23,713,000)
Balance (in shares) at Jun. 30, 2025 1,208,299        
Balance at Jun. 30, 2025 $ 17 192,593 (196,157) (38) (3,585)
Balance (in shares) at Mar. 31, 2025 565,099        
Balance at Mar. 31, 2025 $ 1,000 192,176,000 (178,348,000) (38,000) 13,791,000
Warrants exercised (in shares) 244,319        
Warrants exercised $ 6,000 0 0 0 6,000
Common stock issued upon vesting of restricted stock units (net of taxes) (in shares) 0        
Common stock issued upon vesting of restricted stock units (net of taxes) $ 0 0 0 0 0
Stock-based compensation 0 417,000 0 0 417,000
Consolidated net loss 0 0 (17,809,000) 0 (17,809,000)
Cumulative translation adjustment 0 0 0 0 0
Net loss $ 0 0 (17,809,000) 0 (17,809,000)
Balance (in shares) at Jun. 30, 2025 1,208,299        
Balance at Jun. 30, 2025 $ 17 192,593 (196,157) (38) (3,585)
Issued for cash - sale of common stock, pre-funded and common warrants (in shares) 398,881        
Issued for cash - sale of common stock, pre-funded and common warrants $ 10,000 0 0 0 10,000
Balance (in shares) at Dec. 31, 2025 3,199,228        
Balance at Dec. 31, 2025 $ 3,000 220,997,000 (206,004,000) 10,000 15,006,000
Warrant inducement and exercise of common stock warrants (in shares) 2,122,652        
Warrant inducement and exercise of common stock warrants $ 2,000 0 0 0 2,000
Issuance of common stock in connection with Consulting Agreements (in shares) 6,409        
Issuance of common stock in connection with Consulting Agreements $ 0 0 0 0 0
Issuance of common stock under at-the-market equity program, net of transaction costs (in shares) 3,785        
Issuance of common stock under at-the-market equity program, net of transaction costs $ 0 18,000 0 0 18,000
Warrants exercised (in shares) 2,279        
Warrants exercised $ 0 9,000 0 0 9,000
Common stock issued upon vesting of restricted stock units (net of taxes) (in shares) 1,997        
Common stock issued upon vesting of restricted stock units (net of taxes) $ 0 0 0 0 0
Reclassification of warrant liabilities to equity upon contractual reset of exercise price 0 12,675,000 0 0 12,675,000
Warrant deemed dividend 0 1,765,000 0 0 1,765,000
Deemed dividend in connection with warrant amendment 0 (1,765,000) 0 0 (1,765,000)
Stock-based compensation 0 380,000 0 0 380,000
Consolidated net loss 0 0 (12,845,000) 0 (12,845,000)
Cumulative translation adjustment 0 0 0 (62,000) (62,000)
Deemed dividend in connection with warrant amendments 0 (1,765,000) 0 0 (1,765,000)
Net loss $ 0 0 (12,845,000) 0 (12,845,000)
Balance (in shares) at Mar. 31, 2026 5,336,350        
Balance at Mar. 31, 2026 $ 5,000 234,079,000 (218,849,000) (52,000) 15,183,000
Balance (in shares) at Dec. 31, 2025 3,199,228        
Balance at Dec. 31, 2025 $ 3,000 220,997,000 (206,004,000) 10,000 15,006,000
Consolidated net loss         (20,480,000)
Cumulative translation adjustment         (74,000)
Net loss         (20,480,000)
Balance (in shares) at Jun. 30, 2026 7,100,000        
Balance at Jun. 30, 2026 $ 7,000 238,128,000 (226,484,000) (64,000) 11,587,000
Balance (in shares) at Mar. 31, 2026 5,336,350        
Balance at Mar. 31, 2026 $ 5,000 234,079,000 (218,849,000) (52,000) 15,183,000
Issuance of common stock in connection with Consulting Agreements (in shares) 12,393        
Issuance of common stock in connection with Consulting Agreements $ 0 0 0 0 0
Issuance of common stock under at-the-market equity program, net of transaction costs (in shares) 354,757        
Issuance of common stock under at-the-market equity program, net of transaction costs $ 0 806,000 0 0 806,000
Warrants exercised (in shares) 1,396,500        
Warrants exercised $ 2,000 2,807,000 0 0 2,809,000
Warrant deemed dividend 0 329,000 0 0 329,000
Deemed dividend in connection with warrant amendment 0 (329,000) 0 0 (329,000)
Stock-based compensation 0 436,000 0 0 436,000
Consolidated net loss 0 0 (7,635,000) 0 (7,635,000)
Cumulative translation adjustment 0 0 0 (12,000) (12,000)
Deemed dividend in connection with warrant amendments 0 (329,000) 0 0 (329,000)
Net loss $ 0 0 (7,635,000) 0 (7,635,000)
Balance (in shares) at Jun. 30, 2026 7,100,000        
Balance at Jun. 30, 2026 $ 7,000 $ 238,128,000 $ (226,484,000) $ (64,000) $ 11,587,000